• 1. Transborylation of alkenylboranes with diboranes
  Paula Dominguez-Molano,Gerard Bru,Oriol Salvado,Ricardo J. Maza,Jorge J. Carbó,Elena Fernández Chem. Commun. 2021 57 13361
• 2. Nickel-catalysed decarbonylative borylation of aroyl fluorides
  Zhenhua Wang,Xiu Wang,Yasushi Nishihara Chem. Commun. 2018 54 13969
• 3. Carbon–carbon bond activation by B(OMe)3/B2pin2-mediated fragmentation borylation
  Li Wang,Qi Zhong,Youliang Zou,Youzhi Yin,Aizhen Wu,Quan Chen,Ke Zhang,Jiachen Jiang,Mengzhen Zhao,Hua Zhang Chem. Sci. 2021 12 15104
• 4. A convenient and clean synthetic method for borasiloxanes by Pd-catalysed reaction of silanols with diborons
  Aya Yoshimura,Michiyo Yoshinaga,Hiroshi Yamashita,Masayasu Igarashi,Shigeru Shimada,Kazuhiko Sato Chem. Commun. 2017 53 5822
• 5. Nickel-catalyzed cross-coupling of unactivated alkyl halides using bis(pinacolato)diboron as reductant
  Hailiang Xu,Chenglong Zhao,Qun Qian,Wei Deng,Hegui Gong Chem. Sci. 2013 4 4022

• Other Chemical Reagents Derivatization Reagents
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Recent Advances in the Application of Bis(hexylene glycolato)diboron (230299-21-5) in Chemical Biology and Pharmaceutical Research

Bis(hexylene glycolato)diboron (CAS: 230299-21-5) has emerged as a versatile reagent in chemical biology and pharmaceutical research, particularly in the field of boron chemistry. This compound, characterized by its unique diboron structure, has garnered significant attention due to its applications in Suzuki-Miyaura cross-coupling reactions, a cornerstone of modern synthetic organic chemistry. Recent studies have highlighted its role in facilitating efficient and selective borylation reactions, which are critical for the synthesis of complex bioactive molecules and pharmaceutical intermediates.

One of the most notable advancements in the use of bis(hexylene glycolato)diboron is its application in the synthesis of boron-containing drugs. Boron-based compounds have gained prominence in drug discovery due to their ability to modulate biological targets with high specificity. For instance, recent research has demonstrated the efficacy of bis(hexylene glycolato)diboron in the development of proteasome inhibitors and kinase inhibitors, which are pivotal in the treatment of cancer and inflammatory diseases. The compound's stability and reactivity under mild conditions make it an attractive choice for these applications.

In addition to its role in drug synthesis, bis(hexylene glycolato)diboron has been explored for its potential in bioconjugation strategies. A 2023 study published in the Journal of Medicinal Chemistry reported the successful use of this reagent in the site-specific modification of proteins and peptides. This approach enables the introduction of boron moieties into biomolecules, thereby enhancing their therapeutic properties or enabling novel diagnostic applications. The study underscored the reagent's compatibility with aqueous environments, a critical factor for biological applications.

Another significant development is the integration of bis(hexylene glycolato)diboron into catalytic systems for C-H bond functionalization. Recent work by a team at the University of California, Berkeley, demonstrated that this compound can serve as a mild and efficient boron source in metal-catalyzed C-H borylation reactions. This methodology has been applied to the late-stage functionalization of pharmaceuticals, offering a streamlined approach to diversify drug candidates and optimize their pharmacokinetic properties. The findings were published in ACS Catalysis and have been widely cited for their practical implications.

Despite these advancements, challenges remain in the large-scale application of bis(hexylene glycolato)diboron. Issues such as cost-effectiveness, scalability, and the need for specialized handling due to its moisture sensitivity are areas of ongoing research. However, recent innovations in reagent formulation and stabilization techniques, as reported in a 2024 Nature Communications article, suggest promising solutions to these limitations. The article highlighted the development of polymer-supported derivatives of bis(hexylene glycolato)diboron, which exhibit improved stability and ease of use.

In conclusion, bis(hexylene glycolato)diboron (230299-21-5) continues to be a focal point in chemical biology and pharmaceutical research, with its applications expanding into new frontiers. Its versatility in synthesis, bioconjugation, and catalysis underscores its value as a tool for drug discovery and development. Future research is expected to further elucidate its mechanistic pathways and explore its potential in emerging therapeutic areas, such as targeted protein degradation and boron neutron capture therapy.

• 230299-05-5(Bis(+)-pinanediolatodiboron)
• 230299-17-9(Bis(-)-pinanediolatodiboron)
• 230299-46-4(Bis(2,4-dimethylpentane-2,4-glycolato)diboron)
• 78183-34-3(L-Phenylalanine,L-threonyl-L-histidyl-L-threonyl-L-asparaginyl-L-isoleucyl-L-seryl-L-a-glutamyl-L-seryl-L-histidyl-L-prolyl-L-asparaginyl-L-alanyl-L-threonyl-(9CI))
• 913739-28-3((4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)boronic acid)
• 2247367-07-1(2,2'-Bi-1,3,2-dioxaborolane, 4,4,4',4',5,5,5',5'-octaethyl-)
• 2098552-17-9(4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi-1,3,2-dioxaborolane-2,2'-10B2)
• 73183-34-3(Bis(pinacolato)diborane)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)